Matches in SemOpenAlex for { <https://semopenalex.org/work/W2886234395> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- W2886234395 abstract "The checkpoint kinases ATR and WEE1 protect cells from replication stress (RS), a hallmark of cancer that has potential to be exploited for cancer treatment. ATR and WEE1 inhibitors are in early clinical trials. Here we report selective anti-tumour activity of inhibitors to ATR (AZD6738) and WEE1 (AZD1775) in a subset of diffuse large B-cell lymphoma (DLBCL) cell lines. Using the cell-of-origin (COO) gene expression scoring system, we found enhanced sensitivity to AZD6738 in the activated B-cell like (ABC, n=6) and unclassified cell lines (n=6) with a combined median GI50 of 0.372 µM, compared to germinal centre B-cell like (GCB, n=7) cell lines, with median GI50 of 1.554 µM. Grouping the cells into AZD6738 sensitive (GI50 ≤ 0.5 µM) or insensitive (≥ 1 µM), we show that the ABC/unclassified COO score, together with high c-MYC protein or CDKN2A/B deletion identified 7/8 sensitive cell lines and 0/7 insensitive cell lines. Furthermore, markers of RS correlated with cell line sensitivity. Treatment of cells with 0.5 µM AZD6738 increased the quantity of 53BP1 nuclear bodies by 3-6 fold across the sensitive cell lines compared to only 2 fold across the insensitive cell lines. DNA fibre analysis also showed that sensitive cells lines had slower rates of replication fork progression (0.80 - 1.12 kbmin-1) compared to insensitive cell lines (1.22 - 1.41 kbmin-1). Across the same DLBCL cell line panel sensitivity to the WEE1 inhibitor AZD1775 was positively correlated with AZD6738 sensitivity, although at lower concentrations. However, using OCI-LY19 and DB cells to reflect high and low replication stress respectively, we show that AZD6738 and AZD1775 differ mechanistically in the extent of DNA damage and apoptosis induced within cell cycle phases. Treatment with 1 µM AZD1775 induced S-phase arrest and increased γH2AX+ cells in S/G2 from 4% to 20% in both cell lines at 8 h, indicating replication-associated DNA damage. However, earlier onset of cell death was observed in the OCI-LY19 cells, with 30% γH2AX+ cells undergoing apoptosis at 24 h compared to 25% γH2AX+ DB cells at 72 h. In contrast, AZD6738 only caused G1 arrest in OCI-LY19 daughter cells, with 20% apoptosis at 72 h. These findings are reflected in the anti-tumour activity of the inhibitors in xenograft DLBCL models in vivo. Once-daily, oral dosing of 50 mg/kg/day AZD6738 or 120 mg/kg/day AZD1775 in OCI-LY19 xenograft model showed efficacy with mean % tumour growth inhibition (%TGI) at day 8 of 104.1% (n=10) and 114.3% (n=10) respectively. In addition, the combination of AZD1775 (60 mg/kg/day; monotherapy %TGI=88.7, n=10) and AZD6738 (25 mg/kg/day; monotherapy %TGI=89.8%, n=10) dosed using a 5 day on, 9 day off dosing schedule was tolerated in mice and resulted in tumour regressions (combination %TGI=108.4%, n=8). These data suggest potential for both single agent and combination opportunities for ATR and WEE1 inhibitors in the DLBCL ABC subtype. Citation Format: Lucy A. Young, Lenka Oplustil O9Connor, Zena Wilson, Corinne Reimer, Alan Lau, Jiri Bartek, Mark J. O9Connor. Differential activity of ATR and WEE1 inhibitors in DLBCL subtypes is linked to replication stress and differences in mode of action [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 2826." @default.
- W2886234395 created "2018-08-22" @default.
- W2886234395 creator A5019973961 @default.
- W2886234395 creator A5037780629 @default.
- W2886234395 creator A5055277039 @default.
- W2886234395 creator A5058717267 @default.
- W2886234395 creator A5069830252 @default.
- W2886234395 creator A5075165775 @default.
- W2886234395 creator A5090729430 @default.
- W2886234395 date "2018-07-01" @default.
- W2886234395 modified "2023-09-25" @default.
- W2886234395 title "Abstract 2826: Differential activity of ATR and WEE1 inhibitors in DLBCL subtypes is linked to replication stress and differences in mode of action" @default.
- W2886234395 doi "https://doi.org/10.1158/1538-7445.am2018-2826" @default.
- W2886234395 hasPublicationYear "2018" @default.
- W2886234395 type Work @default.
- W2886234395 sameAs 2886234395 @default.
- W2886234395 citedByCount "0" @default.
- W2886234395 crossrefType "proceedings-article" @default.
- W2886234395 hasAuthorship W2886234395A5019973961 @default.
- W2886234395 hasAuthorship W2886234395A5037780629 @default.
- W2886234395 hasAuthorship W2886234395A5055277039 @default.
- W2886234395 hasAuthorship W2886234395A5058717267 @default.
- W2886234395 hasAuthorship W2886234395A5069830252 @default.
- W2886234395 hasAuthorship W2886234395A5075165775 @default.
- W2886234395 hasAuthorship W2886234395A5090729430 @default.
- W2886234395 hasConcept C120504264 @default.
- W2886234395 hasConcept C1491633281 @default.
- W2886234395 hasConcept C153911025 @default.
- W2886234395 hasConcept C2781252693 @default.
- W2886234395 hasConcept C29537977 @default.
- W2886234395 hasConcept C502942594 @default.
- W2886234395 hasConcept C54355233 @default.
- W2886234395 hasConcept C81885089 @default.
- W2886234395 hasConcept C86803240 @default.
- W2886234395 hasConceptScore W2886234395C120504264 @default.
- W2886234395 hasConceptScore W2886234395C1491633281 @default.
- W2886234395 hasConceptScore W2886234395C153911025 @default.
- W2886234395 hasConceptScore W2886234395C2781252693 @default.
- W2886234395 hasConceptScore W2886234395C29537977 @default.
- W2886234395 hasConceptScore W2886234395C502942594 @default.
- W2886234395 hasConceptScore W2886234395C54355233 @default.
- W2886234395 hasConceptScore W2886234395C81885089 @default.
- W2886234395 hasConceptScore W2886234395C86803240 @default.
- W2886234395 hasLocation W28862343951 @default.
- W2886234395 hasOpenAccess W2886234395 @default.
- W2886234395 hasPrimaryLocation W28862343951 @default.
- W2886234395 hasRelatedWork W1991797776 @default.
- W2886234395 hasRelatedWork W1999713169 @default.
- W2886234395 hasRelatedWork W2062184211 @default.
- W2886234395 hasRelatedWork W2357744919 @default.
- W2886234395 hasRelatedWork W2374858880 @default.
- W2886234395 hasRelatedWork W2376818004 @default.
- W2886234395 hasRelatedWork W2377025740 @default.
- W2886234395 hasRelatedWork W2384261171 @default.
- W2886234395 hasRelatedWork W2388714568 @default.
- W2886234395 hasRelatedWork W2418444121 @default.
- W2886234395 isParatext "false" @default.
- W2886234395 isRetracted "false" @default.
- W2886234395 magId "2886234395" @default.
- W2886234395 workType "article" @default.